Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Anika Therapeutics (ANIK)

Anika Therapeutics (ANIK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 626,266
  • Shares Outstanding, K 14,269
  • Annual Sales, $ 105,560 K
  • Annual Income, $ 18,720 K
  • 60-Month Beta 0.95
  • Price/Sales 5.68
  • Price/Cash Flow 20.00
  • Price/Book 2.33

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.41
  • Number of Estimates 2
  • High Estimate 0.43
  • Low Estimate 0.38
  • Prior Year 0.54
  • Growth Rate Est. (year over year) -24.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
43.19 +2.94%
on 01/27/20
55.10 -19.31%
on 01/06/20
-8.37 (-15.84%)
since 12/27/19
3-Month
43.19 +2.94%
on 01/27/20
75.00 -40.72%
on 10/28/19
-28.90 (-39.39%)
since 10/25/19
52-Week
29.01 +53.26%
on 03/27/19
75.71 -41.28%
on 10/25/19
+7.45 (+20.13%)
since 01/25/19

Most Recent Stories

More News
Anika Therapeutics Closes Acquisition of Parcus Medical

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (HA) technology platform, today...

ANIK : 44.46 (+1.30%)
Anika Therapeuti Shares Down 21.3% Since SmarTrend's Sell Call (ANIK)

SmarTrend identified a Downtrend for Anika Therapeuti (NASDAQ:ANIK) on November 27th, 2019 at $57.75. In approximately 2 months, Anika Therapeuti has returned 21.30% as of today's recent price of $45.45....

ANIK : 44.46 (+1.30%)
Sale of Global Leader in Joint Preservation Incubated at Primo Medical Group

Primo Medical Group, a Massachusetts based medical device manufacturer and incubator, is pleased to announce the sale of its spin-off company Arthrosurface, to Anika Therapeutics.

ANIK : 44.46 (+1.30%)
Botulinum Toxin Non-Surgical Aesthetic Procedures to Escalate the Market Growth

Medical aesthetic procedures are performed for physical appearance improvement by healing conditions including skin laxity, wrinkles, unwanted hair, scars, and several other conditions. Generally, aesthetic...

AGN : 189.00 (+0.43%)
ANIK : 44.46 (+1.30%)
HOLX : 53.72 (unch)
JNJ : 148.75 (+0.29%)
SIEN : 6.41 (-4.97%)
ELOS : 11.00 (unch)
VRX.TO : 30.80 (-3.33%)
Cosmetic Procedures Market Swot Analysis, Opportunities And Development Trends And Key Segments Till 2025

The competitive factors leading to heavy market demand and development scope is analyzed thoroughly. Also, a special focus on distributors, manufacturers, traders and suppliers is provided. The forecast...

ANIK : 44.46 (+1.30%)
CYNO : 66.15 (+0.23%)
HOLX : 53.72 (unch)
SIEN : 6.41 (-4.97%)
ELOS : 11.00 (unch)
VRX.TO : 30.80 (-3.33%)
Medical Aesthetics Market to see strong growth and Market scope in the next few years...

AGN : 189.00 (+0.43%)
ANIK : 44.46 (+1.30%)
HOLX : 53.72 (unch)
SIEN : 6.41 (-4.97%)
ELOS : 11.00 (unch)
VRX.TO : 30.80 (-3.33%)
Anika Therapeutics to Acquire Parcus Medical and Arthrosurface

--Conference Call & Webcast January 8 at 8:30 a.m. ET

ANIK : 44.46 (+1.30%)
Sarepta (SRPT) Looks Good: Stock Adds 7.5% in Session

Sarepta (SRPT) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

SRPT : 111.62 (-0.69%)
ANIK : 44.46 (+1.30%)
Bausch's (BHC) Arazlo Gets FDA Approval for Acne Vulgaris

Bausch (BHC) gets FDA approval for Arazlo Lotion for the topical treatment of acne vulgaris in patients nine years of age or older.

ALKS : 17.15 (-2.67%)
INVA : 13.92 (-2.25%)
ANIK : 44.46 (+1.30%)
BHC : 28.35 (-0.18%)
Seattle Genetics Gets Speedy FDA Nod for Bladder Cancer Drug

The FDA grants accelerated nod to Seattle Genetics' (SGEN) Padcev to treat urothelial cancer. It also assigns Breakthrough Therapy tag to tucatinib for advanced/metastatic HER2-positive breast cancer.

MRK : 86.10 (+0.14%)
RHHBY : 40.9700 (-0.56%)
SGEN : 110.43 (-2.76%)
ANIK : 44.46 (+1.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade ANIK with:

Business Summary

Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative...

See More

Key Turning Points

2nd Resistance Point 45.64
1st Resistance Point 45.05
Last Price 44.46
1st Support Level 43.53
2nd Support Level 42.60

See More

52-Week High 75.71
Fibonacci 61.8% 57.87
Fibonacci 50% 52.36
Fibonacci 38.2% 46.85
Last Price 44.46
52-Week Low 29.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar